Key Insights

Highlights

Success Rate

76% trial completion

Published Results

16 trials with published results (36%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

18.2%

8 terminated out of 44 trials

Success Rate

75.8%

-10.7% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

64%

16 of 25 completed with results

Key Signals

16 with results76% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (13)
Early P 1 (1)
P 1 (11)
P 2 (17)
P 3 (1)

Trial Status

Completed25
Terminated8
Active Not Recruiting6
Withdrawn3
Recruiting1
Unknown1

Trial Success Rate

75.8%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT03880422Not ApplicableRecruiting

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

NCT02346253Not ApplicableActive Not Recruiting

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

NCT01923506Phase 1Active Not Recruiting

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

NCT02023463Phase 1Active Not Recruiting

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

NCT01655836Phase 1Active Not Recruiting

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

NCT02603965Phase 1Completed

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

NCT01823562Phase 1Active Not Recruiting

Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery

NCT02176902Not ApplicableActive Not Recruiting

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

NCT03103321Phase 3Completed

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

NCT02163317Not ApplicableCompleted

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

NCT01555632Not ApplicableWithdrawn

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

NCT02048150Phase 1Completed

Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

NCT02420652Phase 2Terminated

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

NCT02217709Phase 2Completed

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

NCT02446366Not ApplicableUnknown

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

NCT03233555Not ApplicableCompleted

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

NCT03122743Completed

Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer

NCT02250014Phase 1Completed

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

NCT02767921Phase 1Terminated

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

NCT01912820Phase 1Completed

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Scroll to load more

Research Network

Activity Timeline